Marvell's Valuation Crossroads: When Record Growth Isn't Enough to Move the Stock
Published on 09/03/2026 at 05:20 | Editorial boerse-global.de
The arithmetic at Marvell Technology has become uncomfortably simple for shareholders: the company keeps delivering bigger numbers, and the market keeps marking the stock down. Following a record fiscal second quarter reported last Tuesday, shares have slipped another 1.9 percent, extending a slide that has left the equity 12.5 percent below where it traded when the expanded Google partnership was unveiled roughly two weeks earlier. The disconnect between operational momentum and price action has turned Marvell into a case study on whether growth alone can justify a premium valuation in today's AI trade.
Chief executive Matt Murphy described the company's AI-related order intake as "extraordinarily robust" during the earnings call, and guided to accelerating growth through the remainder of the fiscal year. Datacenter revenue — now 79 percent of the total — climbed 46 percent year over year. The market's response was to sell anyway, a pattern that has now repeated for weeks.
While Marvell's growth story is playing out in the semiconductor arena, every business faces its own set of operational risks that need careful management. Just as investors scrutinize Marvell's customer concentration, employers must assess their own workplace vulnerabilities. A free toolkit with 41 ready-to-use templates and checklists helps you document and manage workplace risks systematically. Download the free Risk Assessment Toolkit
The Google Deal's Long Fuse
At the heart of investor unease sits one question: how quickly will the expanded Google collaboration actually translate into revenue? The agreement, broadened in August, grants Google the right to purchase up to nearly 59 million Marvell shares at $206.58 apiece, tied to revenue milestones stretching into fiscal 2033. On paper, the numbers look formidable. But the timeline is extended, and the milestones are contingent on volume commitments that have yet to materialize.
That gap between announcement and execution is where skepticism has taken root. The fear is that revenue contributions from the partnership will land later than the share price has already anticipated, and that Marvell is becoming uncomfortably dependent on a handful of hyperscaler customers. This concentration concern predates the current selloff — Erste Group analyst Hans Engel flagged a price-to-earnings ratio above 73 in mid-July, downgrading the stock to "Hold" on the grounds that the valuation had overshot the sector norm.
Wall Street's Four-Way Split
Rarely has a record quarter produced such divergent analyst messaging. Within days in late August, four firms issued conflicting signals. Craig-Hallum reaffirmed its Buy rating and lifted its price target sharply from $217 to $300. Nearly simultaneously, B. Riley Securities trimmed its target from $345 to $315 — while maintaining Buy. TD Cowen raised its target modestly to $245 but held the line at Hold. Cantor Fitzgerald then confirmed a neutral stance with a $300 target.
Four houses, three different ratings, and a target range spanning $245 to $315. The dispersion is striking — and telling. Even the more bullish firms are trimming targets while others raise theirs, a pattern that cannot be explained by fresh operational data. The fiscal second-quarter results — $2.739 billion in revenue and adjusted earnings per share of $0.94 — have been public for some time. The disagreement appears to be one of perspective: those focused on growth velocity see buying opportunities; those focused on valuation and customer concentration see reasons for caution.
Insider Selling Adds Noise
Complicating the sentiment picture, CEO Matthew J. Murphy sold 7,500 shares in mid-August, worth roughly $1.77 million at a weighted average price of $236.08. The sale was executed under an automated trading plan established in December 2025 — legally unremarkable, but psychologically awkward during a period of falling prices. It is not a warning signal in the strict sense, but it underscores that even management is taking profits while the market debates the stock's worth.
Market volatility reminds us that risk assessment isn't just for investors — it's a legal duty for employers too. Over 37,000 UK businesses already use a free Health & Safety toolkit covering everything from fire safety to COSHH compliance. Whether you're a safety officer or a director, having the right documentation in place protects both your people and your business. Get the free Health & Safety Toolkit
A Stock That Has Come a Long Way — and Fallen Far
The valuation debate is best understood against the backdrop of Marvell's extraordinary run. The shares recently traded at €178.02, roughly 39 percent below the 52-week high of €290.35. Yet even after the sharp pullback, the stock remains up 233 percent over twelve months — a paper that has defended enormous gains despite the recent turbulence.
Technical indicators suggest a market catching its breath rather than capitulating. Thirty-day volatility sits at 88 percent, while the relative strength index reads 43.5 — neither overbought nor oversold. The picture is one of consolidation following a powerful rally, not of structural deterioration.
The Bull and Bear Cases
For optimists, the operating momentum is hard to argue with. Marvell raised its fiscal 2028 revenue outlook to $18 billion, with datacenter growth expected to exceed 60 percent in each of the next two fiscal years — an upgrade from the roughly 50 percent previously communicated. If custom silicon accelerates in the second half as management has indicated, Google-related revenue could arrive sooner than the market currently fears. In that scenario, the recent selloff would look like an overreaction driven by timing anxiety rather than any fundamental weakness.
The bear case deserves equal weight. If revenue recognition from the Google partnership stretches over years while the market demands near-term proof, valuation pressure will persist. Erste Group's concentration warning looms large: much of the growth depends on a small number of hyperscaler clients whose AI infrastructure spending is not guaranteed. Early September brought additional industry-wide concerns about cooling AI chip demand and datacenter expenditure — not Marvell-specific issues, but they hit the stock all the same. B. Riley's recent target cut, even with a maintained Buy rating, shows that even sympathetic analysts are pulling back their expectations without abandoning the core thesis.
What Comes Next
The immediate focal point is October 6, when Marvell hosts its investor day and management is expected to detail its AI infrastructure strategy and custom-silicon roadmap. Until then, every piece of news related to the Google partnership will be scrutinized for whether it confirms or undermines the timing risk that has weighed on the shares.
Should Marvell reaffirm its growth guidance and show early signs of hitting Google-related revenue milestones, the current weakness may well be remembered as a pause in a longer uptrend. Should datacenter momentum falter or custom-chip revenue slip further into the future, the valuation debate will only intensify. For now, the market's patience — or lack thereof — remains the swing factor.
